Pulmatrix financials
$1.56−2.08%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $7.8M | $7.3M | $6.1M | $5.2M | $12.6M | $7.9M | $153.0K | $335.0K | $835.0K |
| Gross profit | $0.00 | $7.8M | $7.3M | $6.1M | $5.2M | $12.6M | $7.9M | $153.0K | $335.0K | $835.0K |
| Gross margin | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | -$5.2M | -$9.8M | -$14.7M | -$18.9M | -$20.2M | -$9.9M | -$20.7M | -$20.4M | -$17.5M | -$29.9M |
| Net income | -$5.2M | -$9.6M | -$14.1M | -$18.8M | -$23.4M | -$19.3M | -$20.6M | -$20.6M | -$18.1M | -$27.8M |
| Net margin | — | −122.5% | −193.5% | −310.3% | −452.1% | −152.8% | −260.4% | −13439.9% | −5389.9% | −3334.5% |
| Diluted EPS | $-1.41 | $-2.62 | $-3.87 | $-5.46 | $-8.63 | $-13.43 | $-24.60 | $-99.60 | $-186.40 | $-376.00 |
| EBITDA | -$5.2M | -$7.0M | -$14.6M | -$18.8M | -$15.4M | -$8.8M | -$13.2M | -$20.1M | -$17.2M | -$17.1M |
| Operating cash flow | -$5.4M | -$10.7M | -$16.0M | -$19.4M | -$19.7M | -$12.5M | $3.2M | -$16.8M | -$14.5M | -$13.3M |
| Free cash flow | -$5.4M | -$11.1M | -$16.7M | -$19.4M | -$19.9M | -$12.8M | $3.2M | -$16.8M | -$14.6M | -$13.7M |
| Diluted shares | 3.7M | 3.7M | 3.7M | 3.4M | 2.7M | 1.4M | 0.8M | 0.2M | 0.1M | 0.1M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.1M | $9.5M | $19.2M | $35.6M | $53.8M | $31.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $4.1M | $9.9M | $34.0M | $41.0M | $58.8M | $38.1M |
| Total liabilities | $329.0K | $996.0K | $16.0M | $9.8M | $11.4M | $15.0M |
| Shareholders' equity | $3.8M | $8.9M | $18.0M | $31.1M | $47.4M | $23.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology